AgeX Therapeutics Reports Second Quarter 2023 Financial Results : vimarsana.com

AgeX Therapeutics, Inc. , a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter and six months ended June 30,...
-Today at 04:06 pm- MarketScreener

Related Keywords

Alabama , United States , Paris , France General , France , America , American , Jean Christophe Renondin , Michaeld West , Juvenescence Limited , Serina Therapeutics Inc , Linkedin , Sovereign Fund Of Oman , Exchange Commission , Agex Therapeutics Inc , Cognate Bioservices , Hackett , Youtube , Transition Services , Exchange Agreement , Compensation Committee , Tuck School Of Business At Dartmouth University , Facebook , Viscogliosi Brothers Acquisition Corp , Twitter , Audit Committee , Charles River Laboratories International , Bryan Garnier Co , Agex Therapeutics , Preferred Stock , Seriesb Preferred Stock , Accounting Standards Update , Financial Statements Going Concern , Quarterly Report , Separation Agreement , Chief Executive Officer , Reverse Bioengineering , Serina Therapeutics , Employment Agreement , Joanne Hackett , Interim Chief Executive , Interim Chief Executive Officer , Corporate Governance Committee , Consulting Agreement , Managing Partner , Vesalius Biocapital , Senior Healthcare Manager , Sovereign Fund , North America , Bryan Garnier , Cognate Bioservices Limited , Tuck School , Dartmouth University , Universite Paris , Private Securities Litigation Reform Act , Annual Report , Markets ,